1-(4-((2-(2-aminopyrimidin-5-yl)-7-methyl-4-morpholinothieno(3,2-d)pyrimidin-6-yl)methyl)piperazin-1-yl)-2-hydroxypropan-1-one,
GDC 0980,
GDC-0980,
GDC0980,
Apitolisib,
1032754-93-0,
GDC-0980,
GDC0980,
RG7422,
(S)-1-(4-((2-(2-aminopyrimidin-5-yl)-7-methyl-4-morpholinothieno[3,2-d]pyrimidin-6-yl)methyl)piperazin-1-yl)-2-hydroxypropan-1-one,
GDC-0980 (RG7422),
GNE 390,
UNII-1C854K1MIJ,
GDC 0980,
Apitolisib (GDC-0980, RG7422),
RG 7422,
1C854K1MIJ,
CHEMBL1922094,
RG-7422,
(2s)-1-(4-{[2-(2-Aminopyrimidin-5-Yl)-7-Methyl-4-(Morpholin-4-Yl)thieno[3,2-D]pyrimidin-6-Yl]methyl}piperazin-1-Yl)-2-Hydroxypropan-1-One,
J-502360,
C23H30N8O3S,
(S)-1-[4-[[2-(2-Aminopyrimidin-5-yl)-7-methyl-4-(morpholin-4-yl)thieno[3,2-d]pyrimidin-6-yl]methyl]piperazin-1-yl]-2-hydroxypropan-1-one,
GNE 390; GDC 0980; RG 7422,
Apitolisib [USAN:INN],
PubChem24448,
Apitolisib (USAN/INN),
Apitolisib(GDC-0980),
SCHEMBL466297,
GTPL7888,
DTXSID50145738,
EX-A041,
QCR-182,
SYN1150,
YOVVNQKCSKSHKT-HNNXBMFYSA-N,
(2S)-1-[4-[[2-(2-aminopyrimidin-5-yl)-7-methyl-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl]piperazin-1-yl]-2-hydroxypropan-1-one,
AOB87742,
BCP02622,
ABP000111,
BDBM50358204,
GDC-0980,RG7422,
GDC-0980-RG7422,
GDC0980(RG7422),
MFCD20274520,
s2696,
ZINC59224388,
AKOS027250725,
BCP9000717,
CS-0590,
DB12180,
GDC-0980.1,
RL00154,
SB20409,
KS-0000079T,
GDC-0980 - RG7422,
AS-16289,
BC638866,
HY-13246,
AB0033740,
SW219472-1,
X7458,
A11023,
D10543,
Q-4032,
CAS:1032754-93-0;GDC-0980,
G-038390,
GDC-0980,CAS:1032754-93-0,
G-038390.1,
RG7422, 1032754-93-0,
(S)-1-(4-((2-(2-aminopyrimidin-5-yl)-7-methyl-4-morpholinothieno[3,2-d]pyrimidin-6-yl)methyl)piperaz,
(S)-1-[4-[[2-(2-Aminopyrimidin-5-yl)-7-methyl-4-(morpholin-4-yl)thieno[3,2-d]pyrimidin-6-yl]methyl]piperazin-1-yl]-2-hydroxypropan-1 -one,
cc-6,
D0N1BU,
D0O6VZ,
GDC-0980/RG7422,
ACN-053695,
B2184,
C569670,
1-(4-((2-(2-aminopyrimidin-5-yl)-7-methyl-4-morpholinothieno(3,2-d)pyrimidin-6-yl)methyl)piperazin-1-yl)-2-hydroxypropan-1-one,